Iloperidone
-
- Application
- Inhibition Assay (InhA), Functional Studies (Func)
- Purpose
- Iloperidone is an atypical antipsychotic for the treatment of schizophrenia symptoms. Hoechst Marion Roussel Inc. made initial inquiries into the drug, however, in May 1996, they discontinued research, and in June 1997 gave research rights to Titan Pharmaceuticals. Titan then handed over worldwide development, manufacturing and marketing rights to Novartis in August 1998. On June 9, 2004, Titan Pharmaceuticals announced that the Phase III development rights have been acquired by Vanda Pharmaceuticals. FDA approved on May 9, 2009.
- Characteristics
-
Tradename: Fanapta, Zomaril
Source of Compound: synthetic
Target: Adrenergic Receptor agonist ,Dopamine Receptor antagonist
Receptor: α-adrenergic receptor,Dopamine receptor
- Purification
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
- Purity
- 97 %
- Formula
- C24H27FN2O4
- Solubility
- DMSO 27 mg/mL, Water <1 mg/mL
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Solid
- Storage
- -20 °C
- Storage Comment
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. - Expiry Date
- 24 months
-
- Background
- GPCR/G protein,Neuroscience
- Molecular Weight
- 426.48 g/mol
- CAS-No
- 133454-47-4
-